Last edition
News about "diabetic macular edema "
Palatin Technologies, the US-based biopharmaceutical company focused on developing medicines that modulate the melanocortin receptor system, announced it has achieved a research milestone under its collaboration with Boehringer Ingelheim, triggering a 6.5 million payment to the company.
Diabetic Macular Edema | 23/09/2025 | By Dineshwori
Remegen Partners with Santen To Commercialise RC28-E in Greater China and Asian Countries
RemeGen, a leading Chinese biopharmaceutical company, has entered into an exclusive licensing agreement for the ophthalmic innovative drug RC28-E with Santen China, a wholly-owned subsidiary of Santen Pharmaceutical.
Diabetic Macular Edema | 19/08/2025 | By Dineshwori | 141
ANI Pharmaceuticals to Acquire Alimera to Expand Rare Disease
ANI Pharmaceuticals, Inc. has announced that ANI will acquire Alimera for USD 5.50 per share in cash at closing and one non-tradable contingent value right (CVR) representing the right to receive up to USD 0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027.
Diabetic Macular Edema | 25/06/2024 | By Aishwarya | 598
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy